Immediate Impact
4 from Science/Nature 66 standout
Citing Papers
Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons
2025 Standout
Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults
2024 Standout
Works of Jo Whelan being referenced
Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current Data
2023
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jo Whelan | 148 | 28 | 41 | 60 | 25 | 309 | |
| A. Tamura | 47 | 34 | 55 | 24 | 304 | ||
| Craig Wooliver | 321 | 22 | 31 | 18 | 346 | ||
| Su‐Chen Lee | 207 | 32 | 18 | 20 | 367 | ||
| Thomas E Schultz | 73 | 3 | 13 | 51 | 16 | 297 | |
| Miyuki Miki | 66 | 37 | 69 | 20 | 352 | ||
| Finch Sc | 58 | 34 | 60 | 16 | 353 | ||
| Francesco Taus | 102 | 27 | 40 | 20 | 329 | ||
| Yuqing Pei | 201 | 24 | 39 | 20 | 347 | ||
| Yao Liang | 181 | 36 | 51 | 22 | 368 | ||
| Sushmita Chakraborty | 78 | 17 | 38 | 22 | 329 |
All Works
Login with ORCID to disown or claim papers
Loading papers...